A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...
News-Medical.Net on MSN
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma ...
15hon MSN
AI tool detects hidden warning signs of disease by analyzing genetic building blocks within cells
McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease ...
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these ...
CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to ...
Mice and newts were applied to the one-step Cre-loxP organism creation technology by TAx9. In this study, the researchers succeeded in synthesizing a Cre-loxP integrated vector by placing a short DNA ...
At first glance, plants may seem passive – but beneath their stillness lies a world of complexity and constant activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback